Hierarchical Network Analysis for Discovering Potential Therapeutic Inhibitors in Head and Neck Cancer
Journal of Medical Sciences · 2026-07 · 46 (4) · 189-195
DOI: 10.4103/jmedsci.jmedsci_40_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Sciences, online erschienen am 30.06.2026. Verfasst von Wen-Sen Lai und 5 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Head and neck squamous cell carcinoma (HNSCC) is characterized by pronounced molecular heterogeneity, immune microenvironment dysregulation, and limited therapeutic options in advanced human papillomavirus (HPV)-negative diseases. System-level approaches may facilitate the identification of core pathogenic mechanisms and clinically applicable therapeutic strategies.
Aim
This study aimed to elucidate system-level mechanisms underlying HNSCC and to identify potential drug repurposing candidates using an integrative systems biology and pharmacology approach.
Methods
Transcriptomic data from the Gene Expression Omnibus dataset GSE148944 (61 HNSCC tumors and 6 normal tissues) were analyzed. Differentially expressed genes (DEGs) were identified using |fold change| ≥ 2 and an adjusted P value ≤ 0.05. Hierarchical systems biology networks (HiSBiNs) quantify perturbations across genes, pathways, subsystems, and system levels using the Kyoto Encyclopedia of Genes and Genomes and meta-z scores. Drug–gene networks integrated DEGs with DrugBank/BindingDB data. Pharmacophore-guided virtual screening of FDA-approved drugs was conducted using Homopharma/SiMMap and iGEMDOCK.
Results
We found 271 upregulated and 36 downregulated DEGs, including SPP1 , ARG1 , MS4A1 , CXCL13 , and SPINK5 , linked to immune regulation and tumor microenvironment. HiSBiN highlighted the immune system (meta-z = highest), and the signaling pathways were the most perturbed. The top candidates were rituximab, tocilizumab, and dasatinib.
Conclusion
This integrative hierarchical systems biology and pharmacology framework elucidated the system-level mechanisms underlying HNSCC and identified hypothesis-generating drug repurposing candidates that warrant further experimental validation, providing a computational foundation, rather than definitive recommendations, for precision therapeutic development, especially in betel nut–prevalent regions, such as Taiwan, where HPV-negative HNSCC predominates.
Zitieren
APA
Lai, W., Kuo, C., Cheng, S., Hsu, S., Yang, C., & Yang, J. (2026). Hierarchical Network Analysis for Discovering Potential Therapeutic Inhibitors in Head and Neck Cancer. Journal of Medical Sciences, 46(4), 189-195. https://doi.org/10.4103/jmedsci.jmedsci_40_26
Vancouver
Lai W, Kuo C, Cheng S, Hsu S, Yang C, Yang J. Hierarchical Network Analysis for Discovering Potential Therapeutic Inhibitors in Head and Neck Cancer. Journal of Medical Sciences. 2026;46(4):189-195. doi:10.4103/jmedsci.jmedsci_40_26
BibTeX
@article{Lai2026,
author = {Lai, Wen-Sen and Kuo, Chao-Yin and Cheng, Sheng-Yao and Hsu, Shih-Wei and Yang, Chien-Yi and Yang, Jinn-Moon},
title = {Hierarchical Network Analysis for Discovering Potential Therapeutic Inhibitors in Head and Neck Cancer},
journal = {Journal of Medical Sciences},
year = {2026},
volume = {46},
number = {4},
pages = {189--195},
doi = {10.4103/jmedsci.jmedsci_40_26}
}
EUVIMED